Metronidazole and glucose injection
Function and Efficacy
This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba target=_blank and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica amoeba can undergo morphological changes in 6-20 hours and all are killed within 24 hours. At a concentration of 0.2 mg/L, the histolytica amoeba can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death.
Ingredients
This product is a compound preparation, its components are: metronidazole 0.2%, glucose 5%.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| MetronidazoleIngredients |
This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica amoeba can undergo morphological changes in 6-20 hours and all are killed within 24 hours. At a concentration of 0.2 mg/L, the histolytica amoeba can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. More |
443-48-1 | 39 | |
| GLUCOSEExcipients |
This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba target=_blank and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica amoeba can undergo morphological changes in 6-20 hours and all are killed within 24 hours. At a concentration of 0.2 mg/L, the histolytica amoeba can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. More |
58367-01-4 | 14 |
Appearance
This product is a colorless or slightly yellow clear liquid.
Indication
Mainly used for the treatment of anaerobic infections.
Usage and Dosage
Intravenous drip 1. The common dose for anaerobic infection in adults is 15 mg/kg body weight for the first intravenous administration (1 g for a 70 kg adult), and the maintenance dose is 7.5 mg/kg body weight, intravenously dripped once every 6 to 8 hours. 2. The common dose for anaerobic infection in children is the same as that for adults.
Adverse Reactions
Adverse reactions occur in 15-30% of cases, with digestive tract reactions being the most common, including nausea, vomiting, loss of appetite, and abdominal cramps, which generally do not affect treatment; neurological symptoms include target=_blank headache, target=_blank dizziness, occasional paresthesia, limb numbness, target=_blank ataxia, target=_blank multiple neuritis, etc., and high doses can cause convulsions. A few cases develop target=_blank urticaria, flushing, itching, target=_blank cystitis, dysuria, metallic taste in the mouth, and leukopenia, all of which are reversible and recover on their own after stopping the drug.
Precautions
It is contraindicated for patients with active central nervous system diseases and blood diseases.
Drug Interactions
This product can enhance the effect of anticoagulant drugs such as warfarin.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
250ml: Metronidazole 0.5g and glucose 12.5g
Manufacturer
Bengbu Fengyuan Pharmaceutical Co., Ltd.
-
Founded in:
2008-09-03 -
Address:
No. 2001 Tushan Road, Bengbu City, Anhui Province -
Tax NO.:
913403006789356353 -
Registered Funds:
88 million yuan -
Website:
-
Email: